# Metabolic Effects of Endogenous Bile Acids After Gastric Bypass Surgery

> **NCT06925997** · EARLY_PHASE1 · RECRUITING · sponsor: **Hvidovre University Hospital** · enrollment: 18 (estimated)

## Conditions studied

- Bariatric Surgery Candidate
- Bile Acid, Elevated Serum
- Glucose Metabolism Disorders

## Interventions

- **DRUG:** Colesevelam

## Key facts

- **NCT ID:** NCT06925997
- **Lead sponsor:** Hvidovre University Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-02
- **Primary completion:** 2027-12
- **Final completion:** 2028-12
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06925997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06925997, "Metabolic Effects of Endogenous Bile Acids After Gastric Bypass Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06925997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*